ARMP
Armata Pharmaceuticals·AMEX
--
--(--)
--
--(--)
3.78 / 10
Netural
Fund flow evaluation stands at 7.56/10, indicating robust money inflows, though the overall trend is labeled negative. Analyst sentiment is overwhelmingly bullish with a 100% Strong Buy rating from one source, yet historical win rates are low. Together, strong fund inflows and bullish analyst views contrast with a muted fundamental base and neutral technical setup, creating a complex but cautiously optimistic outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-05
InstitutionJones Trading
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of ARMP?
- ARMP holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.78/10 (Netural).
